The Pharmalot View
Most Read
‘Everyone was left to guess what went wrong’: An open letter to AstraZeneca’s CEO on transparency
Pharma drew a line in the sand over Covid-19 vaccine readiness — because someone had to
FDA commissioner needs to push back and tell Trump the agency is not part of the ‘deep state’
Where’s the data? In a pandemic, now is no time to sit on Covid-19 trial results
Azar has a ‘tin ear’ when it comes to pricing a potential coronavirus treatment
Memo to the Novartis CEO: When in doubt, give the FDA a heads-up
